Relationships Between Debrisoquine Hydroxylation and Propafenone Pharmacokinetics
- 1 June 1990
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 2 (2) , 114-119
- https://doi.org/10.1007/bf03258249
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- PropafenoneDrugs, 1987
- Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardiaJournal of the American College of Cardiology, 1987
- Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Propafenone for the Treatment of Refractory Complex Ventricular Ectopic ActivityMayo Clinic Proceedings, 1986
- Genetically Determined Variability in Acetylation and Oxidation Therapeutic ImplicationsDrugs, 1985
- The metabolic fate of2H-labelled propafenone in manEuropean Journal of Drug Metabolism and Pharmacokinetics, 1984
- Clinical pharmacology of propafenone.Circulation, 1983
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977